Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1983 Jan 27;110(2):456-62.
doi: 10.1016/0006-291x(83)91171-3.

Additive effects of epinephrine and corticotropin-releasing factor (CRF) on adrenocorticotropin release in rat anterior pituitary cells

Additive effects of epinephrine and corticotropin-releasing factor (CRF) on adrenocorticotropin release in rat anterior pituitary cells

V Giguère et al. Biochem Biophys Res Commun. .

Abstract

The ability of epinephrine to potentiate the action of corticotropin-releasing factor (CRF) was studied in rat anterior pituitary cells in primary culture. Increasing concentrations of epinephrine cause a maximal 6.5-fold stimulation of ACTH release while a 10-fold increase is induced by 5 nM CRF. The two substances exert an additive effect on ACTH release. Although epinephrine alone has no effect on cyclic AMP levels, it causes a maximal 4-fold increase in CRF-induced cyclic AMP accumulation. The stimulatory effect of epinephrine on both parameters is inhibited by the highly specific alpha 1-adrenergic antagonist prazosin but not by the beta-adrenergic antagonist (-)propranolol. Dexamethasone causes a 75% inhibition of ACTH release induced by the combined action of CRF and epinephrine. The present data show that the additive effect of epinephrine on CRF-induced ACTH release is achieved through an alpha-adrenergic receptor and is accompanied by a marked stimulation of intracellular cyclic AMP levels.

PubMed Disclaimer

Similar articles

Cited by

Publication types

LinkOut - more resources